Free release
(41S,13aS)-13a-Ethyl-2,3,5,6,13,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridin-1

(41S,13aS)-13a-Ethyl-2,3,5,6,13,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridin-1

CAS No. :4880-88-0MDL No. :MFCD00064309Formula :C19H22N2OBoiling Point :-Linear Structure Formula :-InChI Key :WYJAPUKIY

Sales:Service@apichina.com
CAS No. :4880-88-0 Brand :Qitai
Formula :C19H22N2O M.W :294.39

Introduction

CAS No. :4880-88-0 MDL No. :MFCD00064309
Formula : C19H22N2O Boiling Point : -
Linear Structure Formula :- InChI Key :WYJAPUKIYAZSEM-MOPGFXCFSA-N
M.W : 294.39 Pubchem ID :71203
Synonyms :
(-)-Vincamone;(-)-Eburnamonine
Chemical Name :(41S,13aS)-13a-Ethyl-2,3,5,6,13,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridin-12(41H)-one

Physicochemical Properties

Num. heavy atoms : 22
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.53
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 92.22
TPSA : 25.24 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -5.94 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.96
Log Po/w (XLOGP3) : 3.03
Log Po/w (WLOGP) : 3.07
Log Po/w (MLOGP) : 3.44
Log Po/w (SILICOS-IT) : 3.26
Consensus Log Po/w : 3.15

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.81
Solubility : 0.0455 mg/ml ; 0.000155 mol/l
Class : Soluble
Log S (Ali) : -3.23
Solubility : 0.175 mg/ml ; 0.000595 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.71
Solubility : 0.00567 mg/ml ; 0.0000193 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 3.92
Signal Word:Danger Class:6.1
Precautionary Statements:P260-P314-P501 UN#:2811
Hazard Statements:H372 Packing Group:
GHS Pictogram: